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The discovery at the end of the 1950s and the beginning of the 1960s that there were enzymes like
threonine deaminase and aspartate transcarbamoylase that failed to follow the expected hyperbolic
behaviour predicted by the Michaelis–Menten equation, raised several questions and induced the
development of mechanisms to explain this peculiar behaviour. At that time it was already known
that the binding of oxygen to haemoglobin did not follow a hyperbolic curve, but a sigmoidal one, and
it was thought that a similar situation probably existed for enzymes with sigmoidal kinetics. In other
words, the observed kinetic behaviour was a consequence of co-operativity in the substrate binding.
Two main models were postulated: those of Monod, Wyman and Changeux in 1965 and of Koshland,
Némethy and Filmer in 1966. Both consider that the different conformations are in equilibrium and
that there is a rapid equilibrium in the binding, which implies that co-operativity could only exist if
there is more than one substrate binding site per enzyme molecule, that is, if the enzyme is an
oligomer. What about monomeric enzymes, could they show kinetic co-operativity? Yes, but only
through mechanisms that imply the existence of enzyme conformations that are not in equilibrium,
and have different kinetic parameters. There are, in fact, very few examples of monomeric enzymes
showing kinetic co-operativity with a natural substrate. The case of “glucokinase” (hexokinase D or
hexokinase IV), a monomeric enzyme with co-operativity with respect to glucose, will be discussed.
& 2015 The Author. Published by Elsevier GmbH. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).Contents
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The year 2013 was important for enzymologists for two
reasons: on the one hand we celebrated the ﬁrst centenary
of the equation of Michaelis and Menten (1913), a corner-
stone in the development of enzymology, and on the other
hand the 50th anniversary of the concept of allostery
(Monod et al., 1963), which illuminates the ﬁeld of meta-
bolic regulation.
Michaelis and Menten, like Henri (1903) before, regarded the
formation of the enzyme–substrate complex as a process at
equilibrium, i.e., the formation of this complex and its
dissociation were considered to be much faster than the
formation and release of the product. Some years later, Briggs
and Haldane (1925) introduced the steady-state hypothesis,
which led to a similar equation changing only the signiﬁcance of
the Michaelis constant. In the equilibrium hypothesis Km can be
considered as a dissociation constant (k1/k1) which is not the
case in the steady-state hypothesis, as another rate constant,
k2, needs to be included ((k1+k2)/k1).
Both equations predict the same sort of kinetic behaviour. If
the experiments are well done, according to the protocol of
Michaelis and Menten the relationship between substrate
concentration and velocity is represented by a hyperbola
passing through the origin. This type of plot was mentioned
by Victor Henri in his thesis, but it was not illustrated.
Michaelis and Menten, however, didn't use this plot but a
semilogarithmic plot (velocity against log[S]). This plot is very
useful to compare mutants or isoenzymes, such as hexokinase
isoenzymes, which differ greatly in substrate afﬁnity
(Cárdenas, 1995), but it is not often used nowadays. The
establishment of a correct experimental protocol was crucial
because it meant that any deviation from hyperbolic beha-
viour was either an artefactual error or needed another
explanation. The linear transformations of the Michaelis–
Menten equation (Woolf plots) (Woolf, 1932) allowed the
possibility of recognizing deviations and the discovery of
enzyme co-operativity.Feedback inhibition and co-operativity: two
sides of the same coin
Although the Woolf plots (Eadie–Hofstee plot, Hanes plot and
Lineweaver–Burk plot) introduced at the beginning of the
1930s (Woolf, 1932) facilitated the task of detecting deviations
from hyperbolic behaviour, more than twenty years passed
before any deviation was reported. There are many reasons
for this long gap, as previously discussed (Cárdenas, 2013).
Probably the main reason was the type of enzymes that
were being studied at the beginning of the 20th century:extracellular enzymes that are not subject to feedback
control. As feedback inhibition and co-operativity are in fact
two sides of the same coin (Cárdenas, 2013), this restricts the
possibilities of observing real deviations. Thus, it is not by
chance that deviations from Michaelian behaviour were only
detected when people started to try to understand feedback
control and to study intracellular enzymes.
In the 1950s there were indications that feedback control
could exist in living organisms: for example, in Escherichia coli
the presence of isoleucine in the culture medium prevented
threonine from being metabolised to isoleucine (Abelson,
1954). Among the ﬁrst enzyme reactions known not to follow
the classical hyperbolic behaviour were threonine deaminase
(Umbarger, 1956) and aspartate transcarbamoylase (Gerhart
and Pardee, 1962)); these enzymes also showed feedback
inhibition. The deviations from hyperbolic behaviour were
observed while studying feedback inhibition and were received
with surprise and worry, as it was not easy to show that they
were not artefacts. Umbarger (1956), studying threonine
deamination, referred to ‘peculiar kinetic behaviour’ because
when the double-reciprocal plot of Lineweaver and Burk was
employed, it was necessary to square the substrate concentra-
tion; the inhibition by isoleucine appeared not to be hyperbolic
either. This led Umbarger to say that: “This property of the
data would be expected if the enzyme combined with two
molecules of substrate or inhibitor. Further experiments are in
progress in an effort to decide whether this peculiar kinetic
behaviour is apparent or real.”
In other words co-operativity and feedback inhibition
were discovered at the same time and both phenomena
required an explanation. This article of Umbarger, of one
single page, constituted a real revolution in enzyme
kinetics, and opened the ﬁeld of regulation by feedback
inhibition through allosteric regulation, although this
term was not yet coined. It reported the following main
kinetic characteristics of an enzyme subject to feedback
inhibition:(i) isoleucine prevents utilisation of threonine by E. coli,
due to inhibition by isoleucine of the deamination of
threonine, the ﬁrst step in its utilisation.(ii) in spite of the structural differences between threonine
and isoleucine, isoleucine behaves as a competitive
inhibitor with respect to threonine.(iii) the kinetic behaviour of threonine deaminase with
respect to its substrate is not hyperbolic.(iv) the inhibition by isoleucine is not hyperbolic either.As these studies were done in crude extracts, this
peculiar kinetic behaviour could have been an artefact,
M.L. Cárdenas12but it was not, as Umbarger's observations (Umbarger
(1956), Umbarger and Brown, 1958) were later conﬁrmed
by Changeux (1961). In his thesis work, he found that the
inhibitory effect of isoleucine was competitive with respect
to threonine, even with puriﬁed enzyme (Umbarger's
experiments were done with crude extracts). This fact led
him to postulate that distinct binding groups would exist on
the surface of the enzyme, and that it would be possible to
desensitise the enzyme, that is, to have a threonine
deaminase still active but insensitive to isoleucine. p-
Chloromercuri-benzoate proved to be very effective for
achieving this (Changeux, 1961). So here are the roots that
would lead to the concept of the allosteric site (Monod
et al., 1963).Aspartate transcarbamoylase: inhibition by
cytidine derivatives
In parallel to the studies of Umbarger, Yates and Pardee
(1956) showed in vitro with crude extracts that cytidine,
and especially cytidine-5-phosphate, acted as competitive
inhibitors with respect to aspartate for the formation of
ureidosuccinic acid (now known as carbamoylaspartate),
the ﬁrst reaction unique to pyrimidine biosynthesis.
This type of inhibition was even more striking than in the
previous case, as here a nucleotide end product was able to
compete with a structurally very different substrate, an
aminoacid. However, as these experiments, like Umbarger's,
were done in crude extracts one could argue that the
inhibition by cytosine derivatives could be indirect: they
could have been transformed in the extract to the real
inhibitor. But, as with threonine deaminase, they proved to
be real, as some years later, Gerhart and Pardee (1962),
using a highly puriﬁed enzyme, conﬁrmed that CTP inhibits
competitively with respect to aspartate.
Furthermore, CTP appeared to bind to a second site
different from the active site, which they called the feed-
back site, as the enzyme could be desensitised without
losing catalytic activity (Gerhart and Pardee, 1962). This led
them to postulate that ‘the bound end product perhaps
inhibits by deforming the enzyme so that the latter has a
low afﬁnity for the substrate’.
The term allosteric site, coined in Paris by Monod and
colleagues, prevailed over the term feedback site, coined in
California by Gerhart and Pardee, probably because of the
review of the former group (Monod et al., 1963).
An interesting point is that although the deviation from
hyperbolic behaviour of aspartate transcarbamoylase is very
obvious to a modern reader, as there is signiﬁcant and very
noticeable co-operativity with respect to aspartate, the
authors downplayed this observation: they only make com-
ments such as: ‘Despite the complex kinetics…’, or ‘the
unusual sigmoidal dependence of the native enzyme…’. It’s
a pity that they did not pay more attention to the
sigmoidicity because their article also illustrates very
clearly the idea that effectors modify the degree of co-
operativity with respect to the substrate: inhibitors by
increasing it and activators by decreasing it.
The lack of emphasis on the co-operativity may perhaps
be because they did not have any explanation for it,
whereas they did have a plausible mechanism for explainingthe feedback inhibition. The same applies to the studies of
Changeux on threonine deaminase.
So, as late as 1962 the observation of sigmoidal depen-
dence was regarded with some suspicion, as it went against
the ideas established in the article of Michaelis and Menten,
and this despite the fact that the co-operativity of oxygen
binding to haemoglobin had been known since 1910 (Hill,
1910). This attitude changed in the middle of the 1960s,
when models for explaining enzyme co-operativity appeared.
Something to bear in mind, to fully appreciate the value of
all these discoveries, is that the concept of allosteric site or
feedback site was in conﬂict with the conceptual view of that
time of enzyme action. The “lock-and-key” image introduced
by Fischer (1894) predominated and implied a certain rigidity
of enzyme structure; with this image, it was very difﬁcult to
conceive of an allosteric site. So, it is not surprising that in
the 1950s researchers such as Umbarger (1956) and Yates and
Pardee (1956), who tried to understand how the ﬁnal product
of a pathway could inhibit the pathway, were completely
astonished to ﬁnd that the inhibitor acted as a competitive
inhibitor of the ﬁrst enzyme of the pathway, in spite of the big
structural difference between substrate and inhibitor. In this
respect Koshland’s ideas of induced ﬁt, in 1958 (Koshland,
1958) played an important role, because with the introduc-
tion of the concept of ﬂexibility in enzyme action, he paved
the way to the allosteric concept.
Models to explain co-operativity and allostery
Two principal models appeared in the mid-1960s, which
attach a functional importance to multiple conformations
(with different kinetic parameters), an idea that originated
with Koshland’s induced ﬁt hypothesis (Koshland, 1958).
These models postulate that the observed kinetic co-
operativity is a consequence of a co-operative binding of
the substrate to an enzyme with several active sites, i.e.,
an enzyme with several subunits. They differ in relation to
the conformational transition (Figure 1).(i) The allosteric model, also called the symmetry model or
the concerted model, proposed by Monod et al. (1965).
Here, all the subunits in each tetramer have the same
conformation; the conformational transition is con-
certed and the symmetry is preserved. In this model
the ligand (substrate, inhibitor or activator) does not
induce a conformational change, but selects a certain
conformation displacing the equilibrium. As with hae-
moglobin the binding of ligand is at equilibrium.(ii) The sequential model proposed by Koshland et al. (1966)
a year later. Here, in each tetramer the subunits can be
in different conformations, because the conformational
transition is not concerted; there is no symmetry. The
ligand induces a conformational change, which may or
may not change the conformation of the neighbouring
subunit, and the conformational equilibrium is disturbed.Both models considered that the following apply:i. the conformational transition is fast in relation to the
catalytic reaction,
Figure 1 Equilibrium binding models to explain co-operativity
and allostery. In the symmetry model proposed by Monod et al.
(1965) all the subunits in each tetramer have the same
conformation (the transition is concerted). The ligands bind
with different afﬁnity to the different conformations and
displace the equilibrium; they do not induce a conformational
change. In the sequential model proposed by Koshland et al.
(1966) the ligand induces a conformational change, disturbing
the equilibrium and the transition is not concerted; there is no
symmetry. In both models the kinetic co-operativity is a
consequence of a co-operative binding of the substrate to the
polymeric enzyme.
13Understanding mechanisms of enzyme co-operativityii. the binding of ligand is at equilibrium, and
iii. the enzymes that present co-operativity are polymeric,
i.e., have multiple subunits.For further comparison between the two models see a
recent review (Cornish-Bowden, 2013).
What about monomeric enzymes? According to these
models a monomeric enzyme with just one active site
cannot have co-operativity with respect to the substrate.
Only if there is a second active site in the same subunit (or a
second site able to bind the substrate) could such an
enzyme show co-operativity with respect to the substrate.
However, there are monomeric enzymes with co-
operative kinetics with its normal substrate and hexokinase
D (“glucokinase”) is a good example (Cárdenas, 1995;
Niemeyer et al., 1975).“Glucokinase” a monomeric enzyme with
kinetic co-operativity
In rat liver there are four isoenzymes able to phosphorylate
glucose (González et al., 1964): hexokinases A, B, C and D
also called I, II, III and IV, respectively. Hexokinase D or IV is
also called “glucokinase” although its speciﬁcity is similar to
the other three (Cárdenas, 1995; Cárdenas et al., 1984a).
However, I shall use here the name “glucokinase”, because
is almost universal in the literature, even though it gives a
misleading impression of the speciﬁcity (Cárdenas, 1995;
Cárdenas et al., 1984a).
Glucokinase is by far the predominant hexokinase iso-
enzyme in hepatocytes (Reyes and Cárdenas, 1984) and has
attracted attention since its discovery because of the
effects of diet and hormones on its level of activity, which
are due to changes in the amount of enzyme, i.e., in gene
expression; it is unique with respect to its molecular mass,
tissue distribution, structure, kinetic properties and func-
tion (Cárdenas, 1995). The glucose uptake by glucokinase in
hepatocytes and pancreatic islets is an essential physiolo-
gical process, crucial for glucose homoeostasis. Glucose-
stimulated insulin release is tightly regulated by islet
glucokinase, which acts as a molecular sensor to couple
glucose metabolism to insulin release (Matschinsky, 1990).
So it is not surprising that glucokinase has acquired pro-
gressively increased interest and importance with the rise in
recent decades of diabetes type 2 as a major problem of
human health (Iynedjian, 2009; Matschinsky, 2009).
When this enzyme was ﬁrst characterised the kinetic co-
operativity with glucose was not reported, but the two
groups that were working on this enzyme detected some
departure from the hyperbolic behaviour (González et al.,
1967; Parry and Walker, 1967). This could have been
expected, as to detect co-operativity it is necessary to do
experiments over a large range of substrate concentrations,
which requires analytical methods sensitive enough to
measure the product at low concentrations, and even more
important, to be able to do the experiments in conditions in
which the enzyme is stable. In the 1960s obtaining pure
enzymes and even partially puriﬁed ones was still difﬁcult,
and progress required knowledge of how to stabilise
enzymes, and the development of puriﬁcation techniques
and of such appropriate materials as ion-exchange resins
and ﬁltration gels. Afﬁnity chromatography, which contrib-
uted greatly to the ﬁeld, only developed in the 1970s. For
further discussion about this point see Cárdenas (2013). In
general, intracellular enzymes tend to be unstable, and it is
the case of glucokinase as it is very sensitive to oxidation; so
it was crucial to learn how to stabilise it. All this explains
why the kinetic co-operativity of glucokinase with respect
to glucose was only reported by Niemeyer et al. (1975), a
decade after its ﬁrst characterisation; this result was conﬁrmed
a year later with pure enzyme and with the evidence that
glucokinase was monomeric (Storer and Cornish-Bowden, 1976;
Holroyde et al., 1976). Afterwards, we proved that it persists as
a monomer in the assay conditions (Cárdenas et al., 1978), a
crucial fact from the point of view of a plausible co-operative
mechanism. The form of enzyme with a higher molecular mass
mentioned in the paper of 1975 may have been a complex of
glucokinase with the regulatory protein, discovered several
M.L. Cárdenas14years afterwards (Van Schaftingen, 1989). A similar degree of
co-operativity is obtained with mannose as substrate (Cárdenas
et al., 1984b). In contrast, with 2-deoxyglucose the kinetic
behaviour is hyperbolic (Monasterio and Cárdenas, 2003).
As the degree of co-operativity was small (Hill coefﬁcient
of 1.5–1.6) there was initially the worry that it could be
artefactual, as glucose could be acting as a stabilising
factor. So we did several experiments to make sure that it
was real. In addition, in contrast to what was discussed in
the previous section, no feedback inhibitor had been
described for this enzyme. So, this appeared to be a very
special case: a monomeric enzyme with co-operativity with
respect to its substrate, and in addition not allosteric: no
feedback site or a second site for binding glucose. All my
efforts to desensitise the enzyme were in vain. Contrary to
the cases of threonine deaminase (Changeux, 1961) and
aspartate transcarbamoylase (Gerhart and Pardee, 1962), as
long as glucokinase retained activity it also retained the co-
operativity (Cárdenas, 1995). There were, however, several
facts that supported the real existence of co-operativity,
with a possible physiological meaning, and in addition
contributed to give hints to postulate a possible mechanism
(Cárdenas, 1995, and references therein):(i) The co-operativity is a very well preserved feature
through evolution. All vertebrate glucokinases that
have been described show co-operativity with glucose
and mannose, with Hill coefﬁcient values between
1.4 and 1.7. This is reviewed in Cárdenas (2004).(ii) The degree of co-operativity depends on the concen-
tration and identity of the nucleotide substrate. Thus,
if the concentration of MgATP is low enough the co-
operativity can be abolished. There is no co-operativity
if the nucleotide substrate is MgITP.(iii) It can be eliminated by the presence of competitive
inhibitors with respect to glucose (mannose, fructose,
2-deoxyglucose, N-acetylglucosamine).Figure 2 Slow-transition model as applied to glucokinase, a
monomeric enzyme. In the absence of the substrate, glucose,
the enzyme exists in a stable conformation E0. The presence of
glucose induces a conformational change to a more active form
E. This transition is slow in relation to catalysis and the
proportion of E increases with the glucose concentration.Kinetic models to explain co-operativity in
monomeric enzymes
The limitation imposed by the models based on co-operative
binding mentioned above, encouraged some people in the
1960s, e. g., Rabin (1967), to seek models that could explain
kinetic co-operativity without needing co-operative bind-
ing: this could be based, for example, on enzyme isomer-
isation during the course of the reaction (Rabin, 1967). This
was initially a sort of intellectual challenge as no mono-
meric enzymes showing deviations from hyperbolic beha-
viour had been described experimentally, at least, none
with natural substrates. This view changed in 1975 with the
discovery of the kinetic behaviour of glucokinase (Niemeyer
et al., 1975), but it was not easy to arrive to a model, and I
considered more than one possibility (Cárdenas et al., 1979,
1984b).
Basically, the existence of kinetic co-operativity implies
the existence of at least two different pathways able to
accomplish the reaction and release the products, and with
different kinetic parameters, so the point is how thesedifferent pathways could be generated. They could derive
from the existence of at least two enzyme conformations, E
and E0 with different activities, whose relative proportion
depends on substrate concentration, and which are not in
equilibrium. Two main models were postulated to explain
the kinetic co-operativity of glucokinase: the mnemonical
model (Ricard et al., 1974; Storer and Cornish-Bowden,
1977) and the slow-transition model (Cárdenas et al.,
1984b; Ainslie et al., 1972), as we have reviewed
(Cornish-Bowden and Cárdenas, 1987, 2004). In both models
the enzyme exists in two distinct forms, E and E0 that are
interconverted relatively slowly, with the more stable form
E0 predominating in the absence of glucose. In the mnemo-
nical model the less stable form E is the one that is released
at the end of the catalytic cycle. The slow-transition model
is somewhat more complicated, as both conformations can
accomplish a catalytic cycle, but with different kinetic
parameters (Figure 2). In both models, as glucose binds in
two different steps, the full rate equation contains terms in
the squared concentration of glucose, thereby allowing
deviations from Michaelis–Menten kinetics.
Before structural information was available, there existed
several different types of information to support the existence
of conformational changes of glucokinase induced by glucose
(Cárdenas, 1995 and references therein):(i) Spectroscopic. Glucose binding enhances intrinsic ﬂuor-
escence of glucokinase. This ﬂuorescence enhancement
is slow and the half-time of the transition depends on
the glucose concentration. This is consistent with a slow
isomerisation between two forms of glucokinase.(ii) Kinetics. Transient states can be detected in the assay
in the presence of glycerol. A burst if the enzyme has
been preincubated with high glucose concentration or a
lag if it has been preincubated without glucose.
Figure 3 Scheme showing the conformational change of
glucokinase induced by the binding of glucose. The open form
corresponds to conformation E0 in Figure 2 and the closed form
to conformation E, the more active form. Adapted from Kamata
et al. (2004).
15Understanding mechanisms of enzyme co-operativityWhen the glucokinase structure was ﬁnally available it
revealed that the free enzyme has a more open conforma-
tion than that of free hexokinase A (brain hexokinase) or
yeast hexokinase; glucose binding induces a big conforma-
tional change (Kamata et al., 2004) (Figure 3).
Although until today no natural allosteric effector (inhi-
bitor or activator) has been described, the enzyme has a
site where an activator could bind. Thus, Grippo and
colleagues (Grimsby et al., 2003) searched for small mole-
cules that could increase the activity of glucokinase by
screening a library of 120,000 structurally diverse synthetic
compounds. One compound increased the enzymatic activ-
ity of glucokinase, and chemical optimisation of this initial
molecule led to the synthesis of glucokinase activators
(Grimsby et al., 2003) that bind to a site 20 Å remote from
the active-site, at the interface between the large and
small domains, on the back of the structure with respect of
the location of the glucose binding site (Dunten et al.,
2004). Activators act as staplers (Kamata et al., 2004) and
close the conformation, increasing the afﬁnity of glucoki-
nase for glucose (Grimsby et al., 2003; Brocklehurst et al.,
2004). However, no natural activator has been described
and probably evolution has not selected one as the sub-
strate, glucose, acts as an activator. In addition, with the
type of diet available in the wild, probably there was no
necessity for developing an activator, or a feedback inhi-
bitor, and now it is too late. The lack of feedback inhibition
appears to have at present dramatic consequences for
human health, because activators—which were seen as
potential medicines for diabetes as they are effective for
decreasing glycaemia, at least temporarily—produce unde-
sirable effects in the long term (Matschinsky, 2013). This is
probably because there is no feedback that controls the
system.
Concluding remarks
Today it has been well established that glucokinase can exist
in more than one conformation and that glucose induces a
conformational transition, that is slow in relation to the
catalytic reaction, and consequently, the different confor-
mations are not in equilibrium. This departure from equili-
brium allows the existence of co-operativity in monomeric
enzymes with only one active site. It has been a long road
where development of technology has played a crucial role
giving rightness to the opinion of Carl Woese that “withoutan adequate technological advance the pathway of progress
is blocked, and without an adequate guiding vision there is
no pathway, there is no way ahead” (Woese, 2004).
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